All SARS-CoV-2 articles – Page 2
-
News New tool can detect fast-spreading SARS-COV-2 variants before they take off
By analysing millions of viral genome sequences from around the world, a team of scientists has uncovered the specific mutations that give SARS-CoV-2 a ‘turbo boost’ in its ability to spread.
-
NewsPapers outline 4 advances for inactivating infectious viruses and bacteria
Four papers provide insights into novel antiviral compounds and methods to inactivate infectious viral particles and bacteria.
-
NewsJapan’s ‘soft’ but not ineffective approach to public health during the COVID-19 pandemic
Researchers found that risk perception and infection prevention behaviors rose during Japan’s COVID-19 state of emergency. After it was lifted, hygienic behaviors persisted, but dread risk perception declined.
-
NewsA new vaccine approach could help combat future coronavirus pandemics
Researchers are able to create a mosaic nanoparticle vaccine - mosaic-8, based on the sarbecovirus receptor-binding proteins (RBDs), which would help combatting SARS-CoV-2 variants and other coronavirus subtypes.
-
NewsScientists discover molecular ‘fingerprint’ of Long Covid in children’s blood
A new study has highlighted the molecular signature of Long Covid in plasma in paediatric age and used an AI tool capable of making the diagnosis based on the results of the blood sample with 93% accuracy.
-
NewsScientists develop new 'twindemic' diagnostic system for rapid viral testing
A team of scientists has recently developed a novel TwinDemic Detection (TDD) system, designed for simultaneous detection of SARS-CoV and influenza A virus (IAV).
-
NewsNew research provides insight into reduced COVID-19 vaccine efficacy in lupus patients
A recent study provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases, highlighting that lupus patients may require tailored vaccination strategies.
-
NewsGenetic mutation linked to higher SARS-CoV-2 risk
Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus’ ability to invade human cells.
-
NewsStudy finds cases of ME/CFS increase following SARS-CoV-2
New findings suggest that infection with SARS-CoV-2, the virus that causes COVID-19, may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
-
NewsThe role of understudied dysfunctional immune cells in severe COVID-19: new research
A new study focuses on understanding how ‘notoriously understudied’ immune cells behave abnormally in patients with severe COVID-19 and provides insights into mechanism behind COVID-19 disease progression.
-
NewsPediatric investigation study confirms the safety of COVID-19 vaccination during pregnancy
A new study shows that maternal COVID-19 vaccination is not associated with adverse health outcomes in infants.
-
NewsA dial for tuning the immune system: Discovery sheds light on why COVID makes some sicker than others
A new study identifies an “immune system tuning dial,” which originated as a bug in the genetic code tens of millions of years ago. When this signaling goes awry and leads the body to under or overreact, people are more likely to develop severe or Long COVID.
-
NewsA new class of antivirals could help prevent future pandemics
A new study introduces a proof-of-concept for a novel class of antivirals that would target a type of enzyme essential not just to SARS, but also many RNA viruses, including Ebola and dengue, as well as cytosolic-replicating DNA viruses, including Pox viruses.
-
NewsNew study reveals how COVID-19 variants hijack human cells
A research team has successfully mapped what they call the “hijackome”, detailing how SARS-CoV-2 variants exploit specific cellular pathways.
-
NewsNew review highlights variant-specific differences in long COVID
Alpha and Delta variants have been linked to a higher prevalence of cardiopulmonary symptoms, such as breathlessness and chest pain, while Omicron infections show fewer severe cardiopulmonary effects but relatively higher incidences of fatigue and brain fog.
-
NewsFirst mouse strain that is susceptible to severe COVID-19 without genetic modification is IDed
Mice with a genetically pure background are susceptible to severe SARS-CoV-2 infection, providing an essential tool to develop vaccines and therapeutics for future coronavirus variants and potential pandemics
-
NewsNew antibody breakthrough offers hope against evolving SARS-CoV-2 variants
Researchers have discovered a groundbreaking monoclonal antibody capable of neutralizing a wide range of SARS-CoV-2 variants, including the elusive Omicron subvariants.
-
NewsTherapeutic tool inhibits the proliferation of the SARS-CoV-2 virus that causes COVID-19
A study led by the University of Barcelona and the Spanish National Research Council’s Institute for Advanced Chemistry of Catalonia (IQAC - CSIC) presents a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19. Source: University of Barcelona The experts Verònica Noé ...
-
NewsCovid-19 virus can damage the retina - even without severe respiratory disease
An experimental study in mice shows that SARS-CoV-2 infection can damage the retinas, with long-term implications for vision.
-
NewsStudy untangles how COVID-19 wreaks widespread damage in the body
A new study sheds light on the pathways that drive organ damage and death in severe COVID-19 and helps explain why survivors of the disease can experience long-term complications.